Inflammatory Melanomas Disrupt Lymphoid Stroma
Author Information
Author(s): Soudja Saïdi M., Henri Sandrine, Mello Marielle, Chasson Lionel, Mas Amandine, Wehbe Maria, Auphan-Anezin Nathalie, Leserman Lee, Van den Eynde Benoît, Schmitt-Verhulst Anne-Marie
Primary Institution: Centre d'Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée, Marseille, France
Hypothesis
How does tumor-associated inflammation affect the organization of secondary lymphoid organs?
Conclusion
Inflammatory tumors disrupt the stromal cell network in secondary lymphoid organs, impairing the recruitment of T and dendritic cells.
Supporting Evidence
- Inflammatory tumors alter the stromal cell network in secondary lymphoid organs.
- These alterations impair the migration of dendritic cells and T lymphocytes.
- Loss of CCL21 production correlates with reduced T-zone areas in lymph nodes.
- Accumulation of immature myeloid cells in lymphoid organs is observed.
- Disruption of lymphoid architecture may hinder effective immune responses.
Takeaway
When tumors cause inflammation, they can mess up the way our immune system's organs work, making it harder for immune cells to do their job.
Methodology
The study used a mouse model of induced melanoma to analyze the effects of tumor-associated inflammation on secondary lymphoid organ architecture and immune cell recruitment.
Potential Biases
Potential bias in the interpretation of results due to the specific model used.
Limitations
The study primarily focuses on a specific mouse model and may not fully represent human conditions.
Participant Demographics
Mice with induced melanoma, specifically TiRP-10B;Ink4a/Arfflox/flox strain.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website